相关实验视频
Updated: Jul 23, 2025

08:48
Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
4.0K
在神经退行性疾病中,植物治疗对线粒体的向
Priyanka Sarkar1, Ashish Kumar1, Partha Sarathi Behera1
1Structural Biology Lab, Pearl Research Park, School of Bio Sciences & Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Advances in protein chemistry and structural biology
|July 12, 2023
概括
线粒体功能障碍会损害神经元的能量供应和脑血流,导致神经退行性疾病. 用植物化合物准线粒体代谢修饰可能为神经系统疾病提供治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 线粒体生物学 线粒体生物学
- 神经学 神经学
背景情况:
- 神经退行性疾病涉及神经元缩,并与线粒体功能障碍有关.
- 神经元在很大程度上依赖于大脑的能量生产,主要来自葡萄糖和线粒体.
- 新出现的证据将神经退行性疾病与脑血管疾病联系起来.
研究的目的:
- 探索线粒体代谢修饰在与衰老相关的神经系统疾病中的作用.
- 为了研究线粒体功能障碍,能量供应和神经退行症中大脑血流之间的联系.
- 评估植物化合物在针对神经系统疾病的线粒体路径方面的潜力.
主要方法:
- 关于神经退行症中线粒体功能的文献综述.
- 分析线粒体能量生产与大脑血流调节之间的相互作用.
- 在与衰老相关的神经疾病期间检查线粒体的代谢变化.
主要成果:
- 线粒体功能障碍会影响神经元的能量供应.
- 被破坏的线粒体功能会对大脑血流和血管扩张产生负面影响.
- 这些干扰导致的能量缺陷导致神经元功能障碍和退化.
结论:
- 线粒体功能障碍是神经退行性疾病发病的一个关键因素,影响神经元能量和脑血流.
- 植物化合物通过向线粒体代谢途径,为治疗干预提供了一个有希望的途径.
- 对植物化合物疗效的进一步研究对于治疗与衰老相关的神经系统疾病是有必要的.
相关概念视频
Electron Transport Chain: Complex I and II
14.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.5K
Mitochondria
13.9K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.9K
Translocation of Proteins into the Mitochondria
3.2K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.2K
Mitochondrial Membranes
11.6K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.6K
ATP Synthase: Mechanism
14.8K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.8K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K

